TechNavio's analysts forecast the Global Blood Glucose Test Strips market to grow at a CAGR of 4.57 percent in terms of revenue over the period 2011-2015. One of the key factors contributing to this market growth is the increasing diabetic population. The Global Blood Glucose Test Strips market has also been witnessing the trend of the adoption of home healthcare devices. However, the presence of non-invasive blood glucose monitoring devices in the market could pose a challenge to the growth of this market.
TechNavio's research report, the Global Blood Glucose Test Strips Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers Global Blood Glucose Test Strips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Abbott Diabetes Care Inc., Bayer Healthcare AG, LifeScan Inc., and Roche Diagnostics Corp.
Other vendors in the market are Hainice Medical Inc., Nipro Diagnostics Inc., and Nova Biomedical Corp.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
01. Executive Summary
03. Market Coverage
04. Market Landscape
04.1 Market Size and Forecast
04.2 Five Forces Analysis
05. Geographical Segmentation
06. Rate of Incidence and Prevalence
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Abbott Diabetes Care Inc.
14.2 Bayer Healthcare AG
14.3 LifeScan Inc.
14.4 Roche Diagnostics Corp.
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Blood Glucose Test Strips Market 2011-2015 (US$ billion)
Exhibit 2: Global Blood Glucose Test Strips Market by Geographical Segmentation 2011
Exhibit 3: Global Blood Glucose Test Strips Market by Vendor Segmentation 2011
TechNavio Announces the Publication of its Report - Global Blood Glucose Test Strips Market 2011-2015
TechNavio today launched its report Global Blood Glucose Test Strips Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers' understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Vendors are increasing their online marketing and promotional activities to increase sales and customer reach. This not only provides customers with easy access, but it also helps vendors reduce their set-up and operational costs. Furthermore, patients are opting for online purchases as there are no time limitations in placing orders. Thus, the increasing use of online marketing tools has a positive impact on the market.''
According to the report, one of the main drivers for this market is the increase in diabetic patients across the globe. Unhealthy lifestyles, changes in diet, and lack of physical exercise have led to an increase in the prevalence of diabetes. As a result, blood glucose test strips are increasingly used to measure blood glucose levels.
Further, the report discusses that one of the main challenges in this market is the availability of advanced non-invasive blood glucose monitoring devices which do not require test strips.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.